Common Medications for Common Ailments
Many people suffer from lingering COVID-19 symptoms, such as fatigue, brain fog, chronic cough, and chest pain, for more than three months. In fact, about 25% of those infected experience these long-term issues.
Recent research indicates that a commonly used diabetes medication can significantly lower the risk of developing these prolonged COVID symptoms.
This affordable drug has also shown promise in slowing aging and may help prevent conditions like cancer, cognitive decline, and heart disease.
Research published in the journal Clinical Infectious Diseases suggests that taking metformin during or shortly after infection with the coronavirus can hinder the persistence of symptoms.
A study from researchers at the University of Minnesota Medical School reviewed multiple evaluations of adults using various coronavirus treatments. They found that on average, one case of long-term COVID-19 infection is prevented for every 50 patients treated with metformin for 14 days.
Notably, metformin was the first treatment to undergo extensive trials to prevent long-term COVID infections across different patient risk categories.
These findings are quite encouraging. Researchers believe that metformin can be effective alone or alongside other COVID treatments. It’s thought to interfere with the virus’s replication process.
In addition to this, metformin’s anti-inflammatory properties could enhance immune response significantly.
Another positive aspect? This drug is generally well-tolerated, having a safety profile that spans over six decades. Although side effects can occur, they are usually mild and digestive in nature, like nausea or diarrhea.
Moreover, the cost is quite low—just 10 to 20 cents per pill, making it accessible for many, including those without insurance.
Still, there are questions about whether this drug can prevent long-term COVID infections in children. Metformin, often considered a “wonder drug,” has been used for decades to treat type 2 diabetes and is taken daily by approximately 200 million people worldwide.
Recent studies also suggest it could become a vital resource for the 150,000 Americans diagnosed with colorectal cancer each year. Beyond that, there’s growing recognition of metformin’s potential in combating obesity and possibly offering anti-aging benefits, along with protections for cardiovascular and nervous systems.
